Rosandra N. Kaplan

16.3k total citations · 4 hit papers
51 papers, 5.7k citations indexed

About

Rosandra N. Kaplan is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Rosandra N. Kaplan has authored 51 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 19 papers in Immunology and 9 papers in Molecular Biology. Recurrent topics in Rosandra N. Kaplan's work include Cancer Cells and Metastasis (13 papers), Immune cells in cancer (12 papers) and CAR-T cell therapy research (9 papers). Rosandra N. Kaplan is often cited by papers focused on Cancer Cells and Metastasis (13 papers), Immune cells in cancer (12 papers) and CAR-T cell therapy research (9 papers). Rosandra N. Kaplan collaborates with scholars based in United States, Australia and United Kingdom. Rosandra N. Kaplan's co-authors include David Lyden, Bethan Psaila, Shahin Rafii, Crystal L. Mackall, Jillian Smith, Meera Murgai, Rimas J. Orentas, Jack F. Shern, Terry J. Fry and Amber Giles and has published in prestigious journals such as Cell, Nature Medicine and Journal of Clinical Oncology.

In The Last Decade

Rosandra N. Kaplan

46 papers receiving 5.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pre-metastatic niches: organ-specific homes for metastases

2017 1.4k citations Bethan Psaila, Rosandra N. Kaplan et al. profile →
4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors

2015 1.3k citations Jack F. Shern, Meera Murgai et al. Nature Medicine profile →
Disruption of CXCR2-Mediated MDSC Tumor Trafficking Enhances Anti-PD1 Efficacy

2014 595 citations Steven L. Highfill, Amber Giles et al. profile →
Why do patients with cancer die?

2024 43 citations Rosandra N. Kaplan et al. profile →

Peers

Countries citing papers authored by Rosandra N. Kaplan

Since Specialization

Citations

This map shows the geographic impact of Rosandra N. Kaplan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosandra N. Kaplan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosandra N. Kaplan more than expected).

Fields of papers citing papers by Rosandra N. Kaplan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosandra N. Kaplan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosandra N. Kaplan. The network helps show where Rosandra N. Kaplan may publish in the future.

Co-authorship network of co-authors of Rosandra N. Kaplan

This figure shows the co-authorship network connecting the top 25 collaborators of Rosandra N. Kaplan. A scholar is included among the top collaborators of Rosandra N. Kaplan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosandra N. Kaplan. Rosandra N. Kaplan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Data from A Phase I, Open-Label, Dose Escalation Study of Enoblituzumab in Children and Young Adults with B7-H3–Expressing Relapsed or Refractory Solid Tumors 2025 ·Kenneth B. DeSantes, Kimberly A. McDowell, Paul M. Sondel, Paul R. Hutson, Rosandra N. Kaplan, Julie R. Park, Meenakshi Hegde, Crystal L. Mackall, John M. Maris	0
2	Spatial Profiling Identifies Regionally Distinct Microenvironments and Targetable Immunosuppressive Mechanisms in Pediatric Osteosarcoma Pulmonary Metastases 2025 ·Cancer Research ·(unknown), Nathan Wong, (unknown), (unknown), (unknown), (unknown), Jessica A. Beck, (unknown), Carly M. Sayers, (unknown), (unknown), (unknown), (unknown), (unknown), Milind Pore, Michael C. Kelly, Amy K. LeBlanc, Jennifer Cotter, Rosandra N. Kaplan, Troy A. McEachron	4
3	A Phase I, Open-Label, Dose Escalation Study of Enoblituzumab in Children and Young Adults with B7-H3–Expressing Relapsed or Refractory Solid Tumors 2025 ·Cancer Research Communications ·Kenneth B. DeSantes, Kimberly A. McDowell, Paul M. Sondel, Paul R. Hutson, Rosandra N. Kaplan, Julie R. Park, Meenakshi Hegde, Crystal L. Mackall, John M. Maris	1
4	Development and validation of pan-cancer lesion segmentation AI-model for whole-body 18F-FDG PET/CT in diverse clinical cohorts 2025 ·Computers in Biology and Medicine ·Fahmida Haque, Alex Chen, Nathan Lay, Jorge A. Carrasquillo, Esther Mena, Liza Lindenberg, (unknown), Philip Eclarinal, (unknown), (unknown), Peter L. Choyke, Karel Pacák, Rosandra N. Kaplan, Frank I. Lin, (unknown), Stephanie A. Harmon	0
5	Abstract 4273: Genetically engineered mesenchymal stromal cells degrade hyaluronic acid to disrupt the ECM and enhance cancer therapy outcomes 2024 ·Cancer Research ·(unknown), (unknown), Wei Ju, Rosandra N. Kaplan	1
6	621 A phase I study of autologous activated NK cells ± rhIL15 in children and young adults with refractory solid tumors 2023 ·SHILAP Revista de lepidopterología ·(unknown), Sabina Kaczanowska, Donna Bernstein, Nan Zhang, Anh Dinh, Robert Somerville, Steven L. Highfill, David F. Stroncek, Kevin C. Conlon, Thomas A. Waldmann, Rosa Nguyen, Melinda S. Merchant, Crystal L. Mackall, Rosandra N. Kaplan	1
7	SOX9 is a key component of RUNX2-regulated transcriptional circuitry in osteosarcoma 2023 ·Cell & Bioscience ·(unknown), (unknown), Gamze Ayaz, Shasha Wang, Hualong Yan, (unknown), Howard H. Yang, Zhen Tao, Maxwell P. Lee, Paul Liu, Rosandra N. Kaplan, Jing Huang	9
8	Infectious complications of CAR T-cell therapy across novel antigen targets in the first 30 days 2021 ·Blood Advances ·Lekha Mikkilineni, Bonnie Yates, Seth M. Steinberg, Shilpa Shahani, John C. Molina, Tara N. Palmore, Daniel W. Lee, Rosandra N. Kaplan, Crystal L. Mackall, Terry J. Fry, Juan Gea‐Banacloche, (unknown), Véronique Nussenblatt, James N. Kochenderfer, Nirali N. Shah	47
9	Innate immune cells in the tumor microenvironment 2021 ·Cancer Cell ·Ming O. Li, Natalie K. Wolf, David H. Raulet, Leila Akkari, Mikäel J. Pittet, Paulo C. Rodrı́guez, Rosandra N. Kaplan, Ariel Munitz, Zemin Zhang, Sijin Cheng, Nina Bhardwaj	108
10	CAR T cells targeting tumor-associated exons of glypican 2 regress neuroblastoma in mice 2021 ·Cell Reports Medicine ·Nan Li, Madeline B. Torres, (unknown), Ruixue Wang, (unknown), Meijie Tian, Christopher M. Dower, Rosa Nguyen, (unknown), Chin‐Hsien Tai, Natalia de Val, Raúl E. Cachau, Xiaolin Wu, Stephen M. Hewitt, Rosandra N. Kaplan, Javed Khan, Brad St. Croix, Carol J. Thiele, Mitchell Ho	34
11	Genetically engineered myeloid cells rebalance the core immune suppression program in metastasis 2021 ·Cell ·Sabina Kaczanowska, Daniel W. Beury, Vishaka Gopalan, (unknown), Haiying Qin, (unknown), Justin A. Drake, (unknown), Meera Murgai, Zachary Rae, Wei Ju, Katherine A. Alexander, Jessica Kline, Cristina F. Contreras, (unknown), (unknown), Sridhar Hannenhalli, Michael C. Kelly, Rosandra N. Kaplan	144
12	Ataxia telangiectasia mutated germline pathogenic variant in adrenocortical carcinoma 2021 ·Cancer Genetics ·Madeline B. Torres, Laurence P. Diggs, Jun S. Wei, Javed Khan, Markku Miettinen, Grace‐Ann Fasaye, Andy Gillespie, Brigitte C. Widemann, Rosandra N. Kaplan, Jeremy L. Davis, Jonathan M. Hernandez, Jaydira Del Rivero	1
13	Pediatric PK/PD Phase I Trial of Pexidartinib in Relapsed and Refractory Leukemias and Solid Tumors Including Neurofibromatosis Type I–Related Plexiform Neurofibromas 2020 ·Clinical Cancer Research ·(unknown), John Glod, (unknown), Miki Kasai, Joanne Derdak, Eva Dombi, (unknown), Daniel W. Beury, Melinda S. Merchant, (unknown), David J. Liewehr, Seth M. Steinberg, Brigitte C. Widemann, Rosandra N. Kaplan	21
14	Anaplastic Lymphoma Kinase Gene Rearrangement in Children and Young Adults With Mesothelioma 2019 ·Journal of Thoracic Oncology ·Idrees Mian, Zied Abdullaev, Betsy Morrow, Rosandra N. Kaplan, Shaojian Gao, Markku Miettinen, David S. Schrump, (unknown), Jun S. Wei, Javed Khan, Svetlana Pack, Raffit Hassan	23
15	New fusion sarcomas: histopathology and clinical significance of selected entities 2019 ·Human Pathology ·Markku Miettinen, Anna Felisiak-Gołąbek, Alejandro Contreras, John Glod, Rosandra N. Kaplan, Jonathan Keith Killian, Jerzy Lasota	58
16	KLF4-dependent perivascular cell plasticity mediates pre-metastatic niche formation and metastasis 2017 ·Nature Medicine ·Meera Murgai, Wei Ju, Matthew G. Eason, Jessica Kline, Daniel W. Beury, Sabina Kaczanowska, Markku Miettinen, Michael J. Kruhlak, Haiyan Lei, Jack F. Shern, Olga A. Cherepanova, Gary K. Owens, Rosandra N. Kaplan	185
17	Elutriated lymphocytes for manufacturing chimeric antigen receptor T cells 2017 ·Journal of Translational Medicine ·David F. Stroncek, Daniel W. Lee, Jiaqiang Ren, Marianna Sabatino, Steven L. Highfill, Hanh Khuu, Nirali N. Shah, Rosandra N. Kaplan, Terry J. Fry, Crystal L. Mackall	55
18	ENABLE (Exportable Notation and Bookmark List Engine): an Interface to Manage Tumor Measurement Data from PACS to Cancer Databases 2017 ·Journal of Digital Imaging ·(unknown), Andrea B. Apolo, (unknown), Mohammadhadi Bagheri, Jason Levine, John Glod, Rosandra N. Kaplan, (unknown), Les Folio	5
19	Activation of Hematopoietic Stem/Progenitor Cells Promotes Immunosuppression Within the Pre–metastatic Niche 2016 ·Cancer Research ·Amber Giles, Caitlin Marie Reid, (unknown), Meera Murgai, (unknown), Steven L. Highfill, Miki Kasai, Linda T. Vahdat, Crystal L. Mackall, David Lyden, Leonard H. Wexler, Rosandra N. Kaplan	117
20	Niche-to-niche migration of bone-marrow-derived cells 2007 ·Trends in Molecular Medicine ·Rosandra N. Kaplan, Bethan Psaila, David Lyden	153

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact